Innovaderm Research, Inc. | Clinical Operations Department
Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The coprimary objectives of the study are to:
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Treatment with a biological product within 12 weeks or 5 half-lives, whichever is longer, prior to Day 1
Treatment with any of the following medications or therapies within 4 weeks or 5 half-lives, whichever is longer, prior to Day 1:
Treatment with any of the following medications or therapies within 1 week, prior to Day 1:
Primary purpose
Allocation
Interventional model
Masking
746 participants in 3 patient groups, including a placebo group
Loading...
Central trial contact
Amgen Call Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal